SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is facing significant market volatility following a launch setback where its latest satellite was deployed into an unsustainable orbit, forcing it to be de-orbited. While the company maintains that insurance will cover the loss and that production schedules remain intact, the community is actively debating the reliability of launch partners, the impact on future constellation deployment timelines, and whether this represents a temporary execution hiccup or a more serious fundamental risk.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors react to high short interest, significant call option positioning, and anticipation surrounding upcoming oncology conference data. Community discussion is sharply divided between bulls optimistic about the clinical potential of the GPS and SLS009 assets, and skeptical voices raising concerns about trial design, trial duration, and financial history.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is experiencing significant market attention as a strategic partner to NVIDIA for quantum calibration and decoding, fueling a broader community narrative that the stock is currently mispriced compared to its peers. Investors are actively discussing the high-beta nature of the stock, analyzing the potential impacts of share unlock provisions, and debating its long-term potential as a key player in the quantum sensing and defense sectors.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is drawing significant investor attention as analysts upgrade price targets, citing accelerating AI infrastructure demand and potential long-term benefits from custom silicon and optical networking partnerships. The community remains actively focused on Marvell's role in scaling hyperscale AI capacity, with many retail bulls highlighting the company's technical breakout as a signal of sustained momentum.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently seeing significant investor attention driven by successful execution of its vertical integration strategy, including the finalized Mynaric acquisition and the expansion of its defense-focused HASTE launch program. The community is closely monitoring upcoming launch missions and the company's role as a critical space infrastructure provider, with discussions centering on its growing backlog, the potential for sustained revenue growth, and sector-wide sentiment bolstered by anticipation surrounding the upcoming SpaceX IPO.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is experiencing a surge in market activity driven by the U.S. government's executive order to fast-track research and regulatory review of psychedelic-based therapies. The stock is a primary focus for community members who are actively debating its potential for National Priority Vouchers, upcoming phase 3 trial results, and broader institutional re-rating as the psychedelic biotech sector gains significant policy tailwinds.

Vanguard World Fund - Vanguard Information Technology ETF

Vanguard Information Technology ETF

Vanguard Information Technology ETF is seeing a surge in community interest as investors discuss its long-term growth potential and strong historical returns. Many are actively debating whether to accumulate shares during market volatility or wait for further pullbacks while highlighting the fund's efficiency and diversification compared to individual tech stocks.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

The Aircoin community is rallying behind the token's unique PvE (Player vs. Everyone) narrative, high holder retention, and significant on-chain supply locking via its 'AirLock' mechanism. Investors are increasingly viewing it as a long-term conviction play on Solana, highlighting its transparent, community-led treasury and organic growth as key differentiators from hype-driven memecoins.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is currently drawing significant attention from investors who view the stock as a compelling turnaround play following years of underperformance, with recent price action testing critical resistance levels. The community is actively debating the stock's stability, weighing a strong dividend yield and operational restructuring efforts against concerns over persistent shipping volume declines and rising fuel costs.

AEVEX Corp. operates as a holding company. It operates through Tactical Systems and Global Solutions segments. The Tactical Systems segment focuses on design, development, and production of autonomous systems including unmanned aerial systems and unmanned surface vessels. The Global Solutions segment offers services and mission support to defense and intelligence customers. The company was founded in 2017 and is headquartered in Solana Beach, CA.

AEVEX Corp. - Ordinary Shares - Class A

AEVEX Corp. is trending following its recent IPO debut, as market participants flock to the drone manufacturer for its exposure to the defense sector and government contracts. Community discussion is heavily focused on the stock's potential for momentum-driven gains, with traders actively debating its valuation compared to peers and monitoring for high-volatility moves amid broader geopolitical concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.

SYRS
Syros Pharmaceuticals Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results:

Historical Earnings

Latest SYRS News

SYRSSyros Pharmaceuticals Inc.